AllPennyStocks.com This Micro Cap Found Mid-Week Success On New Clinical Data

This Micro Cap Found Mid-Week Success On New Clinical Data

This Micro Cap Found Mid-Week Success On New Clinical Data By: Dylan Sikes – AllPennyStocks.com News

Tuesday, February 11, 2025

A biotech based out of New York found a tremendous amount of success on Tuesday after the company announced new clinical data from the ongoing Phase 1 investigator-sponsored trial of INB-100. 

Traders wasted absolutely no time buying up shares of IN8bio Inc. (Nasdaq:INAB), pushing shares of the micro cap up to $0.4177/share (+54.65%) at the session high. This move could be an indication of things to come as this stock appears to be fighting to break out of the multi-month trading range that has been corralling much of the price action as of late. 

IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.


Copyright © 2025 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Travel Tech Play Soars on a Bet on China's Inbound Tourism Reopening
Saskatchewan Natural Hydrogen Story Surges 10% on High Readings
Fiji Gold Producer Gains 10% After Buying Rig to Hit Zone From Underground
Most Popular
{{ index + 1 }}


Back to Top